Table 1.

Baseline Characteristics and Valganciclovir Treatment

Patient	Age, years	KPS	BaselineCCr,mL/min	Prior KS treatment(s)	No. of treatment cycles	KS response
1	78	90	53	None	4	Progression(“mixed”)
2	81	70	87	Liposomal doxorubicin, paclitaxel, etoposide	1	Progression
3	83	80	66	Radiation therapy,vincristine/vinblastine,liposomal doxorubicin,bleomycin,paclitaxel,thalidomide,alitretinoin gel	3	Progression
4	70	90	61	Liposomal doxorubicin,thalidomide	6	Stable
5	58	90	85	None	3	Progression

NOTE. All 5 patients were men C_cr, Creatinine clearance; KPS, Karnofsky performance status; KS, Kaposi sarcoma.